PEREGRINE PHARMACEUTICALS IN's ticker is PPHMXXXX and the CUSIP is 713661304. A total of 74 filers reported holding PEREGRINE PHARMACEUTICALS IN in Q3 2013. The put-call ratio across all filers is 0.30 and the average weighting 0.0%.
Quarter-by-quarter ownership
Value | Shares | Weighting | ||||
---|---|---|---|---|---|---|
Q4 2016 | $16,000 | -11.1% | 53,110 | +28.8% | 0.00% | – |
Q3 2016 | $18,000 | +28.6% | 41,230 | +5.3% | 0.00% | – |
Q2 2016 | $14,000 | -99.4% | 39,139 | -99.3% | 0.00% | -100.0% |
Q1 2016 | $2,464,000 | -60.1% | 5,860,146 | +11.0% | 0.00% | 0.0% |
Q4 2015 | $6,177,000 | +18.4% | 5,279,818 | +3.2% | 0.00% | 0.0% |
Q3 2015 | $5,217,000 | -19.7% | 5,114,747 | +3.2% | 0.00% | -50.0% |
Q2 2015 | $6,494,000 | -4.9% | 4,957,451 | -2.0% | 0.00% | 0.0% |
Q1 2015 | $6,826,000 | -0.6% | 5,056,557 | +2.4% | 0.00% | 0.0% |
Q4 2014 | $6,864,000 | +18.4% | 4,938,152 | +15.8% | 0.00% | 0.0% |
Q3 2014 | $5,798,000 | -29.9% | 4,263,597 | -3.0% | 0.00% | 0.0% |
Q2 2014 | $8,266,000 | -10.8% | 4,396,565 | -9.8% | 0.00% | -33.3% |
Q1 2014 | $9,262,000 | +54.8% | 4,874,832 | +13.3% | 0.00% | +50.0% |
Q4 2013 | $5,982,000 | -0.1% | 4,303,670 | +0.7% | 0.00% | 0.0% |
Q3 2013 | $5,985,000 | +35.7% | 4,275,308 | +25.1% | 0.00% | 0.0% |
Q2 2013 | $4,409,000 | – | 3,417,585 | – | 0.00% | – |
Download |
Other shareholders
Name | Shares | Value | Weighting ↓ |
---|---|---|---|
Delaney Dennis R | 60,000 | $25,000 | 0.05% |
Freedom Investment Management, Inc. | 1,422,314 | $597,000 | 0.04% |
Sterling Global Strategies LLC | 10,000 | $4,000 | 0.02% |
JACOBS LEVY EQUITY MANAGEMENT, INC | 1,009,400 | $424,000 | 0.01% |
CORRADO ADVISORS, LLC | 15,000 | $6,000 | 0.00% |
First Heartland Consultants, Inc. | 17,240 | $7,000 | 0.00% |
Tower Research Capital LLC (TRC) | 37,955 | $16,000 | 0.00% |
Commonwealth Equity Services, Inc | 486,961 | $205,000 | 0.00% |
QS Investors, LLC | 503,400 | $212,000 | 0.00% |
Perceptive Advisors | 24,332 | $10,000 | 0.00% |